Cabozantinib for Late Stage Kidney Cancer

Cabozantinib for Late Stage Kidney Cancer

Da: GRACEcast
0 0 6 anni fa
Cometriq (cabozantinib) is already approved for thyroid cancer and is showing promise for late stage kidney cancer.

Seguici su Facebook